Library
PubMed Central Open Access
research article
Professional
Open access

common variant:c.574-19A>G affects splicing and is pathogenic.

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

Molecular Genetics and Metabolism ReportsLast synced 7/1/2026Status: syncedPMID: 42376640 pmidDOI: 10.1016/j.ymgmr.2026.101331

Albinism is characterized by generalized hypopigmentation and ocular features resulting from impaired melanin biosynthesis. Most known pathogenic variants are rare (MAF G;p.(Tyr342Cys) and a more common intronic variant,:c.574-19 A > G (MAF:0,0087, with 80 homozygotes in the control population GnomADv4.1.0).prediction tools indicated that this intronic variant could alter splicing. RT-PCR analysis on RNA extracted from the patient's blood revealed the skipping of exons 6 and 7, which resulted in the in-frame deletion of 78 amino acids. Protein modelling suggested that this deletion disrupts the GOLD-like domain and leads to the loss of conserved N-glycosylation sites, likely impairing protein folding and intracellular trafficking. These findings provided strong evidence for a deleterious effect on OCA2 function. Therefore, the variant was classified as likely pathogenic, allowing to establish the diagnosis in the patient. The relatively high allele frequency of this variant suggests that it behaves as a hypomorphic allele leading to disease in a compound heterozygous state. This underscores that intronic variants outside the canonical splice sites must be taken in consideration and functionally tested, and that common variants should not be systematically discarded in the diagnosis of albinism, and, similarly, of other rare diseases. ab0005

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.